СÖíÊÓƵapp

СÖíÊÓƵapp Health to Report Fourth Quarter 2021 Financial Results on February 24, 2022

MIAMI, Feb. 17, 2022 (GLOBE NEWSWIRE) -- СÖíÊÓƵapp Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2021 after the close of the U.S. financial markets on Thursday, February 24, 2022. СÖíÊÓƵapp’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on February 24^th beginning at 4:30 p.m. Eastern time.

CONFERENCE CALL & WEBCAST INFORMATION

СÖíÊÓƵapp encourages participants to pre-register for the conference call using the link . Upon registering, participants will receive dial-in numbers, an event passcode and a unique registrant ID to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the start of the call. Alternatively, please dial (888) 869-1189 or (706) 643-5902 and use conference ID 4489338.

To access the live call via webcast, please click on the link . Individual investors and investment community professionals who do not plan to ask a question during the call’s Q&A session are encouraged to listen to the call via the webcast.

For those unable to listen to the live conference call, a replay can be accessed for a period of time on СÖíÊÓƵapp’s website at . A telephone replay will be available beginning approximately two hours after the close of the conference call. To access the replay, please dial (855) 859-2056 or (404) 537-3406, and use conference ID 4489338.

About СÖíÊÓƵapp Health

СÖíÊÓƵapp is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit .

Contacts:

LHA Investor Relations
Yvonne Briggs, 310-691-7100

or
Bruce Voss, 310-691-7100

Released February 17, 2022